Skip to content

AI:AM — AI Genetics and Rare-Disease Diagnosis · September 30, 2026

October 5, 2026 · 1 h 8 min

Show notes

Joel Borgen, author of The Receipt Horizon, discusses writing with ChatGPT and Claude, editorial judgment, and how personalized AI art could change shared culture. Daniel McKinnon, CEO of Gamow Labs, explains how the company acquired a former drug-development lab to test uncertain genetic variants and improve rare-disease diagnosis, alongside discussion of AI agents, OpenAI’s enterprise push, and the need for human oversight.

Chapters

(0:00) AI novels and rare-disease genetics

(1:26) Can Astra Ultrafast keep developers in flow?

(2:09) ChatGPT sign-in makes OpenAI harder to bypass

(2:37) OpenAI apps will run rival models too

(3:11) Eight times faster means less human oversight

(5:15) OpenAI pulled a model; should Anthropic chill?

(5:46) Portable ChatGPT subscriptions cut SaaS trial costs

(7:05) OpenAI's enterprise push is what scares Anthropic

(7:39) Everyone builds a productivity suite now

(8:16) AI agents move humans from documents to decisions

(9:25) Can OpenAI grow without racing to RSI?

(10:34) Meet Joel Borgen, novelist

(11:27) Proof of work: how Joel actually wrote the novel

(15:08) Joel cut fourteen percent from his manuscript

(17:45) Nathan's AI songs reveal a culture gap

(19:03) Astra finally cracked Joel's viola test

(20:35) AI breakthroughs are outrunning cultural norms

(22:47) Could communities choose their own AI future?

(25:40) The Steward's comfort still caps human ambition

(27:57) Would the Steward be a worthy successor?

(29:50) Human taste still matters in AI art

(30:57) Meet Daniel McKinnon of Gamow Labs

(32:06) Why AI genetics needs biological experiments

(35:07) A failed drug program unlocked Gamow's lab

(36:48) Owen's missed diagnosis became a life's mission

(39:18) AI agents can search beyond human cutoffs

(42:11) Sequencing got cheap; interpretation stayed the bottleneck

(44:17) Why Gamow chose diagnostics over screening

(47:37) Reanalysis in a week for ten dollars a genome

(49:25) What Gamow builds on top of frontier models

(52:07) Stronger models can break existing tools

(53:27) Better models are shrinking Gamow's harness advantage

(54:41) Can robots make genetic experiments affordable?

(56:05) Can biological experiments teach genetic AI?

(57:53) Should AI welfare research stay public?

(59:11) Could AI design threats nature never could?

(1:01:00) Government AI upgrades meet decades of data kludges

(1:02:42) Easy name changes weaken names as identity

(1:03:28) Factory and Cognition's feud spooks enterprise buyers

(1:05:23) Safety pledges signed, but no audit exists yet

(1:06:29) Should AI labs fund society's cyberdefenses?

Guests

Daniel McKinnon — CEO, Gamow Labs (𝕏 | LinkedIn)

Joel Borgen — Author, The Receipt Horizon (𝕏)



This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit briefing.ai-in-the-am.com

All episodes of AI:AM

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.